Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?
Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur GraphSearch.
Concept
Kaohsiung Medical University
Résumé
The Kaohsiung Medical University (KMU; ) is a private medical school located in Sanmin District, Kaohsiung, Taiwan.
The university was originally established as Kaohsiung Medical College in 1954 by the former mayor of Kaohsiung City, Chen Chi-chuan, and Tu Tsung-ming, the first Ph.D. of Medical Sciences in Taiwan. At the time of its establishment, the college was the first private institution of its kind in southern Taiwan.
The college hospital, the Chung-Ho Memorial Hospital, was founded three years after the establishment of KMC in June 1957. Chung-Ho Memorial Hospital is the largest medical center in southern Taiwan and serves as a teaching hospital. In 1998, KMC, in agreement with the Kaohsiung Municipal Government, acquired an additional teaching hospital, the Hsiao-kang Hospital.
The Kaohsiung Medical College was re-shaped into the Kaohsiung Medical University (KMU) in August 1999 with the permission of the Ministry of Education, Taiwan.
KMU was rated "superior" by the Ministry of Education, Taiwan in all categories of the "Mid-term School Administration Development Plan."
As of October 2013, KMU has a student-faculty ratio of 13.1:1. The university offers 6 bachelor's, 10 master's and 5 doctoral degree programs.
Up to NT$35 million of scholarships and student grants are offered each year. KMU is the only medical academic institution offering graduate-entry medical programs in Taiwan (the Faculty of Post-Bachelor's degree of Medicine), an admission system based on North American medical institutes.
KMU is associated with eleven major research centers and networks, and is engaged in research partnerships with other universities, government and industry in Taiwan and other countries.
The MedicoGenomic Research Center of Kaohsiung Medical University has successfully developed colorectal cancer diagnostic chip and determined molecular markers for tumors (including DNA and RNA markers) which can be used in the laboratory or clinical tests.
Source officielle
À propos de ce résultat
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.